Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Merck
Cipla
Chubb
Express Scripts
Deloitte

Generated: March 23, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Ibalizumab

« Back to Dashboard

US Patents for Ibalizumab

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Ibalizumab ➤ Sign Up Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein CureVac AG (Tubingen, DE) ➤ Sign Up
Ibalizumab ➤ Sign Up Fusion antibodies for HIV therapy The Rockefeller University (New York, NY) ➤ Sign Up
Ibalizumab ➤ Sign Up Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein CureVac AG (Tubingen, DE) ➤ Sign Up
Ibalizumab ➤ Sign Up Methods for determining resistance or susceptibility to HIV entry inhibitors MONOGRAM BIOSCIENCES, INC. (South San Francisco, CA) ➤ Sign Up
Ibalizumab ➤ Sign Up Bispecific HIV-1 neutralizing antibodies AARON DIAMOND AIDS RESEARCH CENTER (New York, NY) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Ibalizumab

Drugname Country Document Number Estimated Expiration Related US Patent
Ibalizumab Australia 2013220749 2032-02-15 ➤ Sign Up
Ibalizumab Brazil 112014019627 2032-02-15 ➤ Sign Up
Ibalizumab Canada 2862476 2032-02-15 ➤ Sign Up
Ibalizumab China 104114705 2032-02-15 ➤ Sign Up
Ibalizumab China 108570468 2032-02-15 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Moodys
Citi
Chinese Patent Office
Cipla
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.